Hot signal

Submit
Hot signal

Kasper Ernest – Secterary General

Kasper Ernest has worked for the last 9 years in European affairs advocacy in Brussels. From 2009 -2018 he was with the Confederation of Danish Enterprise, since 2015 serving as Director of the EU & International Department. He has also served as the Board Member of several EU-level business organisations, as a Member of the Danish Government’s Implementation Council, and was co-founder of the European Business Services Alliance. In addition, he is an external lecturer at Copenhagen Business School. He holds a Master’s degree in International Business and Politics from Copenhagen Business School and Singapore Management University.

Richard Freudenberg - President - Chief Executive

Richard Freudenberg has worked for the last 26 years in the medicines parallel distribution sector. Active as a practitioner in a UK importer company until 2005, he was subsequently appointed Secretary-General of the British Association of European Pharmaceutical Distributors, a position, which he continues to hold until today. In 2011, he succeeded to the position of Chief Executive of EAEPC, operating from its Brussels HQ. He has been active in the EAEPC Board since 2007, and is currently engaged in his second period as President of the association. He has also been a director since 2015 of the European Medicines Verification Organisation, the pan-industry stakeholder body, tasked with overseeing the implementation of EU Directive 2011/62, the “Falsified Medicines Directive”. In UK, he is also a director of the national organisation charged with developing the FMD repository, SecurMed UK.

Dr. Heinz Kobelt - Director European Affairs

An economist by training, Dr. Heinz Kobelt has been Director European Affairs of the EAEPC, the European Association of Euro-Pharmaceutical Companies - the trade body representing the interests of the parallel distribution industry in Europe - since May 2011, after serving the association as Secretary General from 2005. Previously, he worked as Head of European Government Affairs at Novartis and also held the position of economic and policy analyst at EFTA (the European Free Trade Association). Earlier in his career, he was a member of the Economic Administration of the Swiss Canton of St. Gallen, responsible for economic development and investment promotion.